Sarissa Capital Management
Latest statistics and disclosures from Sarissa Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are IRWD, BIIB, INVA, GILD, NBIX, and represent 95.49% of Sarissa Capital Management's stock portfolio.
- Added to shares of these 4 stocks: NBIX (+$14M), GILD (+$13M), AMRN (+$13M), BCRX.
- Reduced shares in these 2 stocks: , MRSN.
- Sold out of its positions in MRSN, ALKS.
- Sarissa Capital Management was a net seller of stock by $-158M.
- Sarissa Capital Management has $649M in assets under management (AUM), dropping by -12.59%.
- Central Index Key (CIK): 0001577524
Tip: Access up to 7 years of quarterly data
Positions held by Sarissa Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 9 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 28.9 | $188M | 16M | 11.44 |
|
|
| Biogen Idec (BIIB) | 25.6 | $166M | 643k | 258.77 |
|
|
| Innoviva (INVA) | 18.0 | $117M | 7.3M | 16.04 |
|
|
| Gilead Sciences (GILD) | 13.4 | $87M | +16% | 1.1M | 81.01 |
|
| Neurocrine Biosciences (NBIX) | 9.5 | $62M | +28% | 470k | 131.76 |
|
| Amarin Corp Spons Adr New (AMRN) | 3.3 | $22M | +137% | 25M | 0.87 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.9 | $6.0M | +29% | 1.0M | 5.99 |
|
| Vor Biopharma (VOR) | 0.2 | $1.4M | 618k | 2.25 |
|
|
| Regulus Therapeutics (RGLS) | 0.0 | $237k | 185k | 1.28 |
|
Past Filings by Sarissa Capital Management
SEC 13F filings are viewable for Sarissa Capital Management going back to 2013
- Sarissa Capital Management 2023 Q4 filed Feb. 14, 2024
- Sarissa Capital Management 2023 Q3 filed Nov. 14, 2023
- Sarissa Capital Management 2023 Q2 filed Aug. 14, 2023
- Sarissa Capital Management 2023 Q1 filed May 15, 2023
- Sarissa Capital Management 2022 Q4 filed Feb. 14, 2023
- Sarissa Capital Management 2022 Q3 filed Nov. 14, 2022
- Sarissa Capital Management 2022 Q2 filed Aug. 15, 2022
- Sarissa Capital Management 2022 Q1 filed May 16, 2022
- Sarissa Capital Management 2021 Q4 filed Feb. 14, 2022
- Sarissa Capital Management 2021 Q3 filed Nov. 15, 2021
- Sarissa Capital Management 2021 Q2 filed Aug. 16, 2021
- Sarissa Capital Management 2021 Q1 filed May 17, 2021
- Sarissa Capital Management 2020 Q4 filed Feb. 16, 2021
- Sarissa Capital Management 2020 Q3 filed Nov. 16, 2020
- Sarissa Capital Management 2020 Q2 filed Aug. 14, 2020
- Sarissa Capital Management 2020 Q1 filed May 15, 2020